AQR Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Buy |
59,840
+44,313
| +285% | +$107K | ﹤0.01% | 3118 |
|
|
2025
Q1 | $34.3K | Sell |
15,527
-35,835
| -70% | -$79.2K | ﹤0.01% | 3103 |
|
|
2024
Q4 | $280K | Sell |
51,362
-268,107
| -84% | -$1.46M | ﹤0.01% | 2516 |
|
|
2024
Q3 | $2.65M | Sell |
319,469
-453,544
| -59% | -$3.77M | ﹤0.01% | 1357 |
|
|
2024
Q2 | $5.53M | Sell |
773,013
-2,052,862
| -73% | -$14.7M | 0.01% | 975 |
|
|
2024
Q1 | $24.2M | Sell |
2,825,875
-678,236
| -19% | -$5.82M | 0.04% | 461 |
|
|
2023
Q4 | $23M | Buy |
3,504,111
+1,755,108
| +100% | +$11.5M | 0.04% | 461 |
|
|
2023
Q3 | $17.2M | Buy |
1,749,003
+779,838
| +80% | +$7.67M | 0.04% | 515 |
|
|
2023
Q2 | $12M | Sell |
969,165
-322,889
| -25% | -$4.01M | 0.03% | 613 |
|
|
2023
Q1 | $18M | Sell |
1,292,054
-168,598
| -12% | -$2.35M | 0.04% | 501 |
|
|
2022
Q4 | $20.8M | Buy |
1,460,652
+602,852
| +70% | +$8.59M | 0.05% | 465 |
|
|
2022
Q3 | $21.9M | Buy |
857,800
+264,660
| +45% | +$6.76M | 0.05% | 413 |
|
|
2022
Q2 | $16.1M | Buy |
593,140
+441,489
| +291% | +$12M | 0.04% | 550 |
|
|
2022
Q1 | $5.35M | Buy |
151,651
+146,519
| +2,855% | +$5.17M | 0.01% | 836 |
|
|
2021
Q4 | $215K | Buy |
+5,132
| New | +$215K | ﹤0.01% | 2068 |
|